Back to Search
Start Over
Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response
- Source :
- PET Clinics. 14:427-436
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- PET has become an essential tool for staging and response assessment in oncologic imaging. Over the past decade it has also evolved into a tool for image-guided interventions, specifically in the rapidly growing field of interventional oncology. PET-guided biopsies have greater sensitivity and diagnostic yield for fluorodeoxyglucose-avid lesions. Real-time PET imaging can also provide valuable image guidance during therapeutic minimally invasive procedures such as ablation of PET-avid tumors. The increasing use of PET in the assessment of therapeutic response results in earlier identification of disease that is amenable to image-guided therapies.
- Subjects :
- Image-Guided Biopsy
Male
medicine.medical_specialty
medicine.medical_treatment
Interventional oncology
Bone Neoplasms
Radiology, Interventional
Patient Care Planning
030218 nuclear medicine & medical imaging
Fluorodeoxyglucose PET
03 medical and health sciences
0302 clinical medicine
Fluorodeoxyglucose F18
Neoplasms
medicine
Humans
Radiology, Nuclear Medicine and imaging
Radiation treatment planning
Image guidance
Monitoring, Physiologic
Radiation
medicine.diagnostic_test
business.industry
Liver Neoplasms
Interventional radiology
General Medicine
Pet imaging
Ablation
Quality Improvement
Positron emission tomography
Positron-Emission Tomography
030220 oncology & carcinogenesis
Catheter Ablation
Radiation Oncology
Female
Radiology
business
Subjects
Details
- ISSN :
- 15568598
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- PET Clinics
- Accession number :
- edsair.doi.dedup.....ea800eb8ae875ea938cbee59028006f7